Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela M Escalante

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|May 2, 2022
Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical PerspectiveGabriela M Escalante, Lorraine Z Mutsvunguma, Murali Muniraju, et al.
Current Topics in Microbiology and Immunology|July 12, 2025
Non-human Primate Lymphocryptoviruses: Past, Present, and FutureGabriela M Escalante, Ivana G Reidel, Janine Mühe, et al.
Frontiers in Immunology|May 15, 2018
Silicosis and Silica-Induced Autoimmunity in the Diversity Outbred MouseJessica M Mayeux, Gabriela M Escalante, Joseph M Christy, et al.
Viruses|October 26, 2024
A Novel Monoclonal Antibody Against a Modified Vaccinia Ankara (MVA) Envelope Protein as a Tool for MVA Virus Titration by Flow CytometrySimeon Cua, Brenda A Tello, Mafalda A Farelo, et al.
Vaccines|April 10, 2020
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized RabbitsGabriela M Escalante, Joslyn Foley, Lorraine Z Mutsvunguma, et al.
Journal of Virology|May 20, 2024
Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection <i>in vitro</i> or <i>in vivo</i>Murali Muniraju, Lorraine Z Mutsvunguma, Ivana G Reidel, et al.
Vaccine|June 16, 2019
A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbitsDavid H Mulama, Lorraine Z Mutsvunguma, Jennifer Totonchy, et al.
Virology|August 5, 2019
Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopesLorraine Z Mutsvunguma, Esther Rodriguez, Gabriela M Escalante, et al.
Journal of Virology|May 31, 2019
Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell TypesMurali Muniraju, Lorraine Z Mutsvunguma, Joslyn Foley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2017
Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFNK Michael Pollard, Gabriela M Escalante, Hua Huang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|May 2, 2022
Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical PerspectiveGabriela M Escalante, Lorraine Z Mutsvunguma, Murali Muniraju, et al.
Current Topics in Microbiology and Immunology|July 12, 2025
Non-human Primate Lymphocryptoviruses: Past, Present, and FutureGabriela M Escalante, Ivana G Reidel, Janine Mühe, et al.
Frontiers in Immunology|May 15, 2018
Silicosis and Silica-Induced Autoimmunity in the Diversity Outbred MouseJessica M Mayeux, Gabriela M Escalante, Joseph M Christy, et al.
Viruses|October 26, 2024
A Novel Monoclonal Antibody Against a Modified Vaccinia Ankara (MVA) Envelope Protein as a Tool for MVA Virus Titration by Flow CytometrySimeon Cua, Brenda A Tello, Mafalda A Farelo, et al.
Vaccines|April 10, 2020
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized RabbitsGabriela M Escalante, Joslyn Foley, Lorraine Z Mutsvunguma, et al.
Journal of Virology|May 20, 2024
Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection <i>in vitro</i> or <i>in vivo</i>Murali Muniraju, Lorraine Z Mutsvunguma, Ivana G Reidel, et al.
Vaccine|June 16, 2019
A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbitsDavid H Mulama, Lorraine Z Mutsvunguma, Jennifer Totonchy, et al.
Virology|August 5, 2019
Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopesLorraine Z Mutsvunguma, Esther Rodriguez, Gabriela M Escalante, et al.
Journal of Virology|May 31, 2019
Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell TypesMurali Muniraju, Lorraine Z Mutsvunguma, Joslyn Foley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2017
Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFNK Michael Pollard, Gabriela M Escalante, Hua Huang, et al.
Pageof 2